Code | 9987C | ||||||||||
MA number | EU/1/18/1340/001 | ||||||||||
Product Form: | sol inj 1x2 ml/300 mg (liek.inj.skl.) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU Orphan | ||||||||||
MAH, country: | Takeda Pharmaceuticals International AG Ireland Branch, Ireland | ||||||||||
Therapeutic Class: | 87 - VARIA I | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Route of admin.: | Subcutaneous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 22.11.2018 |
SmPC + PL: | European Medicines Agency's database |
Safety feature | Yes |
Data update: | 30.08.2023 |